Literature DB >> 20002146

De novo epileptic confusion in the elderly: a 1-year prospective study.

Olivier Veran1, Philippe Kahane, Pierre Thomas, Sophie Hamelin, Cecile Sabourdy, Laurent Vercueil.   

Abstract

PURPOSE: Nonconvulsive status epilepticus (NCSE) is clinically difficult to diagnose, especially in old patients without epilepsy, and requires electroencephalography (EEG) for diagnosis. Its incidence among elderly patients with confusion of unknown origin (CUO) remains undetermined.
METHODS: A 1-year prospective study was conducted in patients aged 60 years or older, for whom EEG was requested because of confusion considered to be of unknown origin after initial clinical, biologic, and imaging investigations. Diagnosis criteria included a validated clinical assessment scale to confirm confusion.
RESULTS: Of 44 patients with confirmed CUO, 7 presented with de novo NCSE. NCSE population had a mean age of 76 years (range, 60-97 years). No statistically significant differences were found between NCSE patients and others for age, drugs, presence of myoclonia, eyelid myoclonia, tachycardia, or agitation. In contrast, an acute onset (<24 h), gender (100% female among NCSE patients), and lack of clinical response to simple commands were significantly associated with NCSE. No differences between the two groups were evidenced for mortality and morbidity (length of hospitalization, social outcome, and so on). DISCUSSION: Almost 16% of patients aged 60 or older with confusion of unknown origin had NCSE, according to this first prospective study. Female patients with rapid onset (<24 h) of symptoms and lack of response to simple commands were at a higher risk of presenting with NCSE.

Entities:  

Mesh:

Year:  2009        PMID: 20002146     DOI: 10.1111/j.1528-1167.2009.02410.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  3 in total

Review 1.  [Diagnosis and treatment of status epilepticus in the intensive care unit].

Authors:  W Müllges
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-05-03       Impact factor: 0.840

2.  Tau reduction prevents disease in a mouse model of Dravet syndrome.

Authors:  Ania L Gheyara; Ravikumar Ponnusamy; Biljana Djukic; Ryan J Craft; Kaitlyn Ho; Weikun Guo; Mariel M Finucane; Pascal E Sanchez; Lennart Mucke
Journal:  Ann Neurol       Date:  2014-08-13       Impact factor: 10.422

Review 3.  Managing Status Epilepticus in the Older Adult.

Authors:  Stephane Legriel; Gretchen M Brophy
Journal:  J Clin Med       Date:  2016-05-11       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.